Global Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country

The global mortality data for trachea, bronchus, or lung malignant neoplasms show Hungary leading with 88.5 deaths per 100,000 persons, while Mexico reports the lowest at 5.2. From 2023 to 2024, countries like Portugal and Bulgaria experienced increases, while significant decreases were recorded in the United States and Iceland. Over five years, most countries showed a downtrend with the United States, Iceland, and Slovakia reflecting notable declines.

Future trends to watch include innovations in early detection and treatment, policy changes impacting smoking rates, and global initiatives to reduce air pollution which may further lower mortality rates. Monitoring these trends can provide better insights into long-term global health outcomes.

Top countries in Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country

# 10 Countries Units (Deaths) Per Hundred Thousand Persons Last Year YoY 5-years CAGR
1 1 Hungary 88.5 2023 +0.23% -0.16% View data
2 2 Croatia 71.7 2023 +0.7% +0.028% View data
3 3 Japan 61.2 2023 +0.66% +0.8% View data
4 4 Poland 59.9 2023 +0.67% -0.85% View data
5 5 Denmark 56.6 2023 -1.57% -0.76% View data
6 6 Netherlands 55.8 2023 -1.41% -1.51% View data
7 7 Germany 53.7 2023 0% -0.15% View data
8 8 Romania 52.7 2023 +0.57% +0.35% View data
9 9 Canada 52 2023 -0.38% -0.68% View data
10 10 Bulgaria 51.1 2023 +0.59% +1.47% View data

Top Countries about Lung Cancer